Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-693,436
Closed -$46.8M 816
2025
Q3
$46.8M Buy
+693,436
New +$46M 0.35% 97
2025
Q2
Sell
-25,836
Closed -$1.6M 749
2025
Q1
$1.6M Sell
25,836
-220,903
-90% -$14.6M 0.02% 319
2024
Q4
$17.8M Buy
+246,739
New +$19.3M 0.22% 148

Other funds holding HOLX

Freestone Grove Partners's HOLX Position: Q4 2025 in Review

Freestone Grove Partners sold out of Hologic (HOLX) in Q4 2025, closing a stake of 693,436 shares — an estimated $46.8M sold.

Freestone Grove Partners first reported a position in HOLX in Q4 2024 and held it in 3 quarters. The position peaked at $46.8M in Q3 2025. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • Freestone Grove Partners reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
  • Freestone Grove Partners sold 693,436 Hologic shares in Q4 2025, an estimated $46.8M.
  • Freestone Grove Partners first reported a position in Hologic in Q4 2024 and held it in 3 quarters.
  • Freestone Grove Partners's Hologic position peaked at $46.8M in Q3 2025.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Freestone Grove Partners's 13F filing for Q4 2025, filed 17 Feb 2026.